Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge

Wen Tssann Liu, Wei Ting Lin, Chung Chin Tsai, Chuan Chang Chuang, Chin Len Liao, Huang Chi Lin, Yao Wen Hung, Shih Shiung Huang, Chung Chih Liang, Hui Ling Hsu, Hsian-Jenn Wang, Yu Tien Liu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A recombinant vaccine strain SL3261/pLT105 of attenuated aroA Salmonella enterica serovar Typhimurium SL3261 strain expressing a secreted dengue virus type 2 non-structural NS1 and Yersinia pestis F1 (Caf1) fusion protein, rNS1:Caf1, was generated. Immunological evaluation was performed by prime-boost vaccine regimen. Oral immunization of mice with 1 × 109 cfu of SL3261/pLT105 only induced low levels of NS1-specific antibody response and protective immunity following dengue virus challenge. The parenteral NS1 protein priming-oral Salmonella boosting protocol enhanced both NS1-specific serum IgG response and protective efficacy as compared to mice immunized with each type vaccine alone. Addition of an antifungal antibiotic amphotericin B (AmB) to Salmonella vaccine further enhanced the synergic effects of prime-boost vaccine regimen on the elicited NS1-specific serum IgG response and the protective efficacy. Together, the results demonstrated that the rNS1:Caf1 producing Salmonella SL3261/pLT105 strain fails to provide effective protection as an oral vaccine alone despite co-administration of AmB as an adjuvant capable of enhancing the immune responses, and moreover, the protein priming-oral Salmonella vaccine boosting approach in combination with AmB as an immunization regimen may have the potential to be further explored as an alternative approach for dengue vaccine development.

Original languageEnglish
Pages (from-to)5852-5861
Number of pages10
JournalVaccine
Volume24
Issue number31-32
DOIs
Publication statusPublished - Jul 26 2006
Externally publishedYes

Fingerprint

Salmonella Vaccines
Dengue virus
Dengue Virus
Synthetic Vaccines
amphotericin B
Amphotericin B
mouth
Salmonella
Vaccination
Vaccines
vaccination
immune response
vaccines
mice
Immunization
Proteins
Dengue Vaccines
proteins
Immunoglobulin G
Yersinia pestis

Keywords

  • Amphotericin B
  • Dengue virus
  • NS1
  • Prime-boost regimen
  • Salmonella vaccine
  • Yersinia pestis

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge. / Liu, Wen Tssann; Lin, Wei Ting; Tsai, Chung Chin; Chuang, Chuan Chang; Liao, Chin Len; Lin, Huang Chi; Hung, Yao Wen; Huang, Shih Shiung; Liang, Chung Chih; Hsu, Hui Ling; Wang, Hsian-Jenn; Liu, Yu Tien.

In: Vaccine, Vol. 24, No. 31-32, 26.07.2006, p. 5852-5861.

Research output: Contribution to journalArticle

Liu, WT, Lin, WT, Tsai, CC, Chuang, CC, Liao, CL, Lin, HC, Hung, YW, Huang, SS, Liang, CC, Hsu, HL, Wang, H-J & Liu, YT 2006, 'Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge', Vaccine, vol. 24, no. 31-32, pp. 5852-5861. https://doi.org/10.1016/j.vaccine.2006.04.066
Liu, Wen Tssann ; Lin, Wei Ting ; Tsai, Chung Chin ; Chuang, Chuan Chang ; Liao, Chin Len ; Lin, Huang Chi ; Hung, Yao Wen ; Huang, Shih Shiung ; Liang, Chung Chih ; Hsu, Hui Ling ; Wang, Hsian-Jenn ; Liu, Yu Tien. / Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge. In: Vaccine. 2006 ; Vol. 24, No. 31-32. pp. 5852-5861.
@article{afb7364ac48d42d7bcc15f4a1bb975e9,
title = "Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge",
abstract = "A recombinant vaccine strain SL3261/pLT105 of attenuated aroA Salmonella enterica serovar Typhimurium SL3261 strain expressing a secreted dengue virus type 2 non-structural NS1 and Yersinia pestis F1 (Caf1) fusion protein, rNS1:Caf1, was generated. Immunological evaluation was performed by prime-boost vaccine regimen. Oral immunization of mice with 1 × 109 cfu of SL3261/pLT105 only induced low levels of NS1-specific antibody response and protective immunity following dengue virus challenge. The parenteral NS1 protein priming-oral Salmonella boosting protocol enhanced both NS1-specific serum IgG response and protective efficacy as compared to mice immunized with each type vaccine alone. Addition of an antifungal antibiotic amphotericin B (AmB) to Salmonella vaccine further enhanced the synergic effects of prime-boost vaccine regimen on the elicited NS1-specific serum IgG response and the protective efficacy. Together, the results demonstrated that the rNS1:Caf1 producing Salmonella SL3261/pLT105 strain fails to provide effective protection as an oral vaccine alone despite co-administration of AmB as an adjuvant capable of enhancing the immune responses, and moreover, the protein priming-oral Salmonella vaccine boosting approach in combination with AmB as an immunization regimen may have the potential to be further explored as an alternative approach for dengue vaccine development.",
keywords = "Amphotericin B, Dengue virus, NS1, Prime-boost regimen, Salmonella vaccine, Yersinia pestis",
author = "Liu, {Wen Tssann} and Lin, {Wei Ting} and Tsai, {Chung Chin} and Chuang, {Chuan Chang} and Liao, {Chin Len} and Lin, {Huang Chi} and Hung, {Yao Wen} and Huang, {Shih Shiung} and Liang, {Chung Chih} and Hsu, {Hui Ling} and Hsian-Jenn Wang and Liu, {Yu Tien}",
year = "2006",
month = "7",
day = "26",
doi = "10.1016/j.vaccine.2006.04.066",
language = "English",
volume = "24",
pages = "5852--5861",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "31-32",

}

TY - JOUR

T1 - Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge

AU - Liu, Wen Tssann

AU - Lin, Wei Ting

AU - Tsai, Chung Chin

AU - Chuang, Chuan Chang

AU - Liao, Chin Len

AU - Lin, Huang Chi

AU - Hung, Yao Wen

AU - Huang, Shih Shiung

AU - Liang, Chung Chih

AU - Hsu, Hui Ling

AU - Wang, Hsian-Jenn

AU - Liu, Yu Tien

PY - 2006/7/26

Y1 - 2006/7/26

N2 - A recombinant vaccine strain SL3261/pLT105 of attenuated aroA Salmonella enterica serovar Typhimurium SL3261 strain expressing a secreted dengue virus type 2 non-structural NS1 and Yersinia pestis F1 (Caf1) fusion protein, rNS1:Caf1, was generated. Immunological evaluation was performed by prime-boost vaccine regimen. Oral immunization of mice with 1 × 109 cfu of SL3261/pLT105 only induced low levels of NS1-specific antibody response and protective immunity following dengue virus challenge. The parenteral NS1 protein priming-oral Salmonella boosting protocol enhanced both NS1-specific serum IgG response and protective efficacy as compared to mice immunized with each type vaccine alone. Addition of an antifungal antibiotic amphotericin B (AmB) to Salmonella vaccine further enhanced the synergic effects of prime-boost vaccine regimen on the elicited NS1-specific serum IgG response and the protective efficacy. Together, the results demonstrated that the rNS1:Caf1 producing Salmonella SL3261/pLT105 strain fails to provide effective protection as an oral vaccine alone despite co-administration of AmB as an adjuvant capable of enhancing the immune responses, and moreover, the protein priming-oral Salmonella vaccine boosting approach in combination with AmB as an immunization regimen may have the potential to be further explored as an alternative approach for dengue vaccine development.

AB - A recombinant vaccine strain SL3261/pLT105 of attenuated aroA Salmonella enterica serovar Typhimurium SL3261 strain expressing a secreted dengue virus type 2 non-structural NS1 and Yersinia pestis F1 (Caf1) fusion protein, rNS1:Caf1, was generated. Immunological evaluation was performed by prime-boost vaccine regimen. Oral immunization of mice with 1 × 109 cfu of SL3261/pLT105 only induced low levels of NS1-specific antibody response and protective immunity following dengue virus challenge. The parenteral NS1 protein priming-oral Salmonella boosting protocol enhanced both NS1-specific serum IgG response and protective efficacy as compared to mice immunized with each type vaccine alone. Addition of an antifungal antibiotic amphotericin B (AmB) to Salmonella vaccine further enhanced the synergic effects of prime-boost vaccine regimen on the elicited NS1-specific serum IgG response and the protective efficacy. Together, the results demonstrated that the rNS1:Caf1 producing Salmonella SL3261/pLT105 strain fails to provide effective protection as an oral vaccine alone despite co-administration of AmB as an adjuvant capable of enhancing the immune responses, and moreover, the protein priming-oral Salmonella vaccine boosting approach in combination with AmB as an immunization regimen may have the potential to be further explored as an alternative approach for dengue vaccine development.

KW - Amphotericin B

KW - Dengue virus

KW - NS1

KW - Prime-boost regimen

KW - Salmonella vaccine

KW - Yersinia pestis

UR - http://www.scopus.com/inward/record.url?scp=33745652909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745652909&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.04.066

DO - 10.1016/j.vaccine.2006.04.066

M3 - Article

VL - 24

SP - 5852

EP - 5861

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 31-32

ER -